Canton Strategic Holdings (CNTN) Current Assets (2020 - 2026)
Canton Strategic Holdings (CNTN) posted Current Assets of $43.1 million for Q1 2026, up 147.81% on a QoQ basis from $17.4 million in Q4 2025, and up 2493.48% year-over-year from $1.7 million in Q1 2025.
Canton Strategic Holdings (CNTN) Current Assets (2020 - 2026) Analysis & Trends
Canton Strategic Holdings' Current Assets history runs 7 years deep, the most recent figure standing at $43.1 million for Q1 2026.
- Quarterly Current Assets rose 2493.48% year-over-year to $43.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.1 million (up 2493.48% YoY) and the FY2025 annual result came in at $17.4 million, up 367.16% from the prior year.
- Current Assets was $43.1 million for Q1 2026 at Canton Strategic Holdings, up from $17.4 million in the prior quarter.
- Across five years, Current Assets topped out at $43.1 million in Q1 2026 and bottomed at $1.7 million in Q1 2025.
- A 5-year average of $9.4 million and a median of $7.7 million in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2025 — Current Assets tumbled 81.31% — and 2026, when it jumped 2493.48%.
- Canton Strategic Holdings' Current Assets stood at $6.7 million in 2022, then jumped by 63.66% to $10.9 million in 2023, then slumped by 66.0% to $3.7 million in 2024, then soared by 367.16% to $17.4 million in 2025, then soared by 147.81% to $43.1 million in 2026.
- Business Quant data shows CNTN's Current Assets at $43.1 million in Q1 2026, $17.4 million in Q4 2025, and $7.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 73.04 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 3.59 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 6.60 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 1.97 Bn |
| 10 | Canton Strategic Holdings | 425.80 Mn | 425.80 Mn | - | 43.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.09 Mn |
| Dec 31, 2025 | 17.39 Mn |
| Sep 30, 2025 | 7.70 Mn |
| Jun 30, 2025 | 2.53 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 3.72 Mn |
| Sep 30, 2024 | 5.25 Mn |
| Jun 30, 2024 | 8.26 Mn |
| Mar 31, 2024 | 8.89 Mn |
| Dec 31, 2023 | 10.95 Mn |
| Sep 30, 2023 | 3.17 Mn |
| Jun 30, 2023 | 4.60 Mn |
| Mar 31, 2023 | 4.72 Mn |
| Dec 31, 2022 | 6.69 Mn |
| Sep 30, 2022 | 8.02 Mn |
| Jun 30, 2022 | 10.25 Mn |
| Mar 31, 2022 | 12.09 Mn |
| Dec 31, 2021 | 621,677.00 |
| Dec 31, 2020 | 294,798.00 |